CYTOVANT
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics. The company focuses on developing modified T-cell receptor therapeutics and dendritic cell vaccines that target tumor antigens to improve tumor cells therapy and treatment.
CYTOVANT
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2019-04-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.cytovant.com
Total Employee:
1+
Status:
Active
Contact:
+86 21 5090 0866
Email Addresses:
[email protected]
Total Funding:
23.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Euro ASP.NET Pound Sterling Japanese Yen Alibaba HiChina DNS China Ministry Of Public Security
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Current Employees Featured
Founder
Investors List
BNH
BNH investment in Venture Round - Cytovant
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Venture Round - Cytovant
Smilegate Investment
Smilegate Investment investment in Venture Round - Cytovant
POSCO Venture Capital
POSCO Venture Capital investment in Venture Round - Cytovant
